(RTTNews) – AstraZeneca (AZN) on Monday unveiled fitness generation company Evinova to meet the wishes of fitness professionals, regulators and patients.
Evinova was developed with AstraZeneca and strategic collaborations with Parexel and Fortrea. Global virtual fitness responses will be used through clinical trial sponsors, clinical trial organizations, clinical trial site care teams, and patients. Evinova will function as an independent fitness generation company indoors. from AstraZeneca.
Evinova is expected to streamline the design and conduct of AstraZeneca’s clinical trials and reduce the time and burden of developing new medicines. This can bring healthcare closer to patients’ homes and reduce the burden on fitness systems.
In addition, Evinova will look for opportunities in the realm of remote virtual patient monitoring and virtual therapy.
Pascal Soriot, Chief Executive Officer of AstraZeneca, said: “We believe that the combination of Evinova’s clinical expertise and the pleasure of developing AI-based virtual technologies at scale provides a genuine opportunity to fundamentally improve patient care, drive healthcare transformation and reduce carbon emissions.